1. Home
  2. ADXN vs LRHC Comparison

ADXN vs LRHC Comparison

Compare ADXN & LRHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADXN
  • LRHC
  • Stock Information
  • Founded
  • ADXN 2002
  • LRHC 2004
  • Country
  • ADXN Switzerland
  • LRHC United States
  • Employees
  • ADXN N/A
  • LRHC N/A
  • Industry
  • ADXN Biotechnology: Pharmaceutical Preparations
  • LRHC
  • Sector
  • ADXN Health Care
  • LRHC
  • Exchange
  • ADXN Nasdaq
  • LRHC Nasdaq
  • Market Cap
  • ADXN 8.5M
  • LRHC 8.4M
  • IPO Year
  • ADXN N/A
  • LRHC 2023
  • Fundamental
  • Price
  • ADXN $8.86
  • LRHC $5.36
  • Analyst Decision
  • ADXN
  • LRHC
  • Analyst Count
  • ADXN 0
  • LRHC 0
  • Target Price
  • ADXN N/A
  • LRHC N/A
  • AVG Volume (30 Days)
  • ADXN 23.3K
  • LRHC 11.6K
  • Earning Date
  • ADXN 11-21-2025
  • LRHC 11-19-2025
  • Dividend Yield
  • ADXN N/A
  • LRHC N/A
  • EPS Growth
  • ADXN N/A
  • LRHC N/A
  • EPS
  • ADXN N/A
  • LRHC N/A
  • Revenue
  • ADXN $210,347.00
  • LRHC $78,037,079.00
  • Revenue This Year
  • ADXN $86.57
  • LRHC N/A
  • Revenue Next Year
  • ADXN N/A
  • LRHC N/A
  • P/E Ratio
  • ADXN N/A
  • LRHC N/A
  • Revenue Growth
  • ADXN N/A
  • LRHC 54.92
  • 52 Week Low
  • ADXN $6.51
  • LRHC $4.33
  • 52 Week High
  • ADXN $12.05
  • LRHC $142.40
  • Technical
  • Relative Strength Index (RSI)
  • ADXN 48.84
  • LRHC 29.42
  • Support Level
  • ADXN $8.53
  • LRHC $5.35
  • Resistance Level
  • ADXN $10.55
  • LRHC $7.04
  • Average True Range (ATR)
  • ADXN 0.72
  • LRHC 0.42
  • MACD
  • ADXN -0.03
  • LRHC -0.22
  • Stochastic Oscillator
  • ADXN 9.86
  • LRHC 11.32

About ADXN Addex Therapeutics Ltd

Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.

About LRHC La Rosa Holdings Corp.

La Rosa Holdings Corp operates in the U.S. residential real estate market. It is a holding company for agent-centric, technology-integrated, cloud-based, multi-service real estate companies. The company's business is organized based on the services it provides internally to the agents and to the public, which are residential and commercial real estate brokerage, franchising, real estate brokerage education and coaching, and property management. The company has six reportable segments, namely: Real Estate Brokerage Services (Residential), Franchising Services, Coaching Services, Property Management, Real Estate Brokerage Services (Commercial), and Title Settlement and Insurance. It derives maximum revenue from the Real Estate Brokerage Services (Residential) segment.

Share on Social Networks: